AC
SWBI icon

Andromeda Capital’s Smith & Wesson SWBI Stock Holding History

Andromeda Capital’s Portfolio SWBI Stock Details SWBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-98,876
Closed -$758K – 101
2013
Q2 		$758K Buy
+98,876
New +$689K 0.11% 72

Other funds holding SWBI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Trafelet Capital Management New York $11.8M AUM 13.32% 1-Year Est. Return

Andromeda Capital's SWBI Position: Q3 2013 in Review

Andromeda Capital sold out of Smith & Wesson (SWBI) in Q3 2013, closing a stake of 98,876 shares — an estimated $758K sold.

Andromeda Capital first reported a position in SWBI in Q2 2013 and held it in 1 quarter. The position peaked at $758K in Q2 2013. 162 funds tracked by Wall St. Rank hold SWBI as of Q3 2013.

  • Andromeda Capital reported no remaining Smith & Wesson position as of Q3 2013 after selling out during the quarter.
  • Andromeda Capital sold 98,876 Smith & Wesson shares in Q3 2013, an estimated $758K.
  • Andromeda Capital first reported a position in Smith & Wesson in Q2 2013 and held it in 1 quarter.
  • Andromeda Capital's Smith & Wesson position peaked at $758K in Q2 2013.
  • 162 funds tracked by Wall St. Rank held Smith & Wesson as of Q3 2013.

Based on Andromeda Capital's 13F filing for Q3 2013, filed 14 Nov 2013.